Literature DB >> 32762267

Microwave ablation versus transcatheter arterial embolization for large hepatic hemangiomas: clinical outcomes.

Yaoping Shi1, Jingjing Song2, Min Ding1, Xiaoyin Tang1, Zhi Wang1, Jiachang Chi1, Tao Wang1, Jiansong Ji2, Bo Zhai1.   

Abstract

PURPOSE: To evaluate the safety and effect of microwave ablation (MWA) compared with transcatheter arterial embolization (TAE) for the treatment of large hepatic hemangiomas.
MATERIALS AND METHODS: A total of 135 patients with symptomatic or/and enlarging hepatic hemangiomas (5-10 cm) from two centers underwent either MWA (n = 82) or TAE (n = 53) as first-line treatment. We compared the two groups in terms of radiologic response, clinical response, operative time, postoperative analgesic requirements, hospital stay and complications.
RESULTS: MWA had a significantly higher rate of complete radiologic response (89.0% vs. 37.7%, p<.001) and complete clinical response (88.6% vs. 69.2%, p=.046), fewer minor complications (43.9% vs. 66.0%, p=.019), shorter time of using analgesics (p<.001) and shorter hospital stays (p=.003) than did TAE. The operative time and major complications were comparable between the two groups.
CONCLUSION: Both MWA and TAE are safe and effective in treating patients with large hepatic hemangiomas. MWA had a higher rate of complete response than did TAE, and it was associated with fewer minor complications, faster recovery and shorter hospital stay.

Entities:  

Keywords:  Hepatic hemangioma; microwave ablation; transcatheter arterial embolization; retrospective study; clinical outcomes

Mesh:

Year:  2020        PMID: 32762267     DOI: 10.1080/02656736.2020.1766122

Source DB:  PubMed          Journal:  Int J Hyperthermia        ISSN: 0265-6736            Impact factor:   3.914


  3 in total

1.  Safety and efficacy of microwave versus radiofrequency ablation for large hepatic hemangioma: a multicenter retrospective study with propensity score matching.

Authors:  Jian Kong; Ruize Gao; Shilun Wu; Yaoping Shi; Tao Yin; Shigang Guo; Zonghai Xin; Aolei Li; Xinliang Kong; Demin Ma; Bo Zhai; Wenbing Sun; Jun Gao
Journal:  Eur Radiol       Date:  2022-01-29       Impact factor: 5.315

2.  To Systematically Evaluate and Analyze the Efficacy and Safety of Transcatheter Arterial Chemoembolization (TACE) in the Treatment of Primary Liver Cancer.

Authors:  Xiao Yang; Tingting Lan; Hui Zhong; Zujian Zhang; Hui Xie; Youwei Li; Wen Huang
Journal:  J Healthc Eng       Date:  2022-03-21       Impact factor: 2.682

3.  Ultrasound-guided percutaneous sclerotherapy versus surgical resection in the treatment of large hepatic hemangiomas: a retrospective study.

Authors:  Zepeng Lin; Xiaofeng Zhu; Jian Zhou
Journal:  BMC Surg       Date:  2022-04-07       Impact factor: 2.102

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.